HUMANA INC
For the period ended Apr 17, 2025. Filed Mar 7, 2025.
View on SEC.govAbout this filing
What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.
Apr 17, 2025 · Filed Mar 7, 2025
HUM$433.74+5.3%Stored close · as of Nov 6, 2026
Contents
Proxy Summary
2025 ANNUAL MEETING OF STOCKHOLDERS
| Date: | Thursday, April 17, 2025 |
|---|---|
| Time: | 1:00 p.m., Eastern Time |
| Record Date: | February 28, 2025 |
| Place: | www.virtualshareholdermeeting.com/HUM2025 |
GENERAL INFORMATION
| Stock Symbol: | HUM |
|---|---|
| Exchange: | NYSE |
| Shares Outstanding at Record Date: | 120,692,633 |
| Corporate Address: | 500 West Main Street Louisville, KY 40202 |
| Corporate Website: | www.Humana.com |
| Investor Relations Website: | https://humana.gcs-web.com/ |
VOTING OVERVIEW
| Items of Business | BoardRecommendation | |
| 1. | Elect the eleven (11) director nominees named in the proxy statement. | FOR |
| 2. | Ratify the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for 2025. | FOR |
| 3. | Non-binding advisory vote to approve the compensation of the Company’s Named Executive Officers. | FOR |
| 4. | Consider any other business properly brought before the meeting. |
HOW TO VOTE YOUR SHARES
You may vote if you were a stockholder as of the close of business on February 28, 2025.
| Online www.proxyvote.com | By Mail Complete, sign, date, and return your proxy card in the envelope provided. |
| By Phone Call the phone number located on the top of your proxy card. | During the Meeting Attend our virtual annual meeting and cast your vote using the webcast voting options. |
BOARD OF DIRECTORS NOMINEES
| Director Nominee Name | |||||
|---|---|---|---|---|---|
| Kurt J. Hilzinger Chairman of the Board | ✓ | 64 | Male | White | 07/2003 |
| James A. Rechtin | — | 54 | Male | White | 07/2024 |
| Raquel C. Bono, M.D. | ✓ | 68 | Female | Asian | 09/2020 |
| Frank A. D’Amelio | ✓ | 67 | Male | White | 09/2003 |
| David T. Feinberg, M.D. | ✓ | 62 | Male | White | 03/2022 |
| Wayne A.I. Frederick, M.D. | ✓ | 53 | Male | Black/ African American | 02/2020 |
| John W. Garratt | ✓ | 56 | Male | White | 02/2020 |
| Karen W. Katz | ✓ | 68 | Female | White | 09/2019 |
| Marcy S. Klevorn | ✓ | 65 | Female | White | 02/2021 |
| Jorge S. Mesquita | ✓ | 63 | Male | White | 02/2021 |
| Gordon Smith | ✓ | 66 | Male | White | 10/2024 |
NAMED EXECUTIVE OFFICERS
| Executive Officer Name | ||||
|---|---|---|---|---|
| James A. Rechtin President & Chief Executive Officer | 54 | Male | White | 01/2024 |
| Bruce D. Broussard Former Chief Executive Officer | 62 | Male | White | 12/2011 |
| Susan M. Diamond Chief Financial Officer | 51 | Female | White | 07/2019 |
| David E. Dintenfass President, Enterprise Growth | 54 | Male | White | 02/2024 |
| Sanjay K. Shetty, M.D. President, CenterWell | 51 | Male | Asian | 04/2023 |
| George Renaudin II President, Insurance | 56 | Male | White | 02/2023 |
| i | Humana | 2025 Proxy Statement • Proxy Summary |
|---|
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.